《糖尿病相关眼病防治多学科中国专家共识》(2021年版)解读

2022-05-15 哈尔滨医科大学附属第一医院内分泌科 临床内科杂志

糖尿病相关眼病严重威胁着糖尿病患者的生存质量,为进一步加深临床医生对其的规范化认识与管理,中华医学会糖尿病学分会糖尿病视网膜病变学组发表了《糖尿病相关眼病防治多学科中国专家共识》,本共识针对糖尿病性视

中文标题:

《糖尿病相关眼病防治多学科中国专家共识》(2021年版)解读

发布日期:

2022-05-15

简要介绍:

糖尿病相关眼病严重威胁着糖尿病患者的生存质量,为进一步加深临床医生对其的规范化认识与管理,中华医学会糖尿病学分会糖尿病视网膜病变学组发表了《糖尿病相关眼病防治多学科中国专家共识》,本共识针对糖尿病性视网膜病变及其他眼部并发症患者的筛查、评估与规范化综合管理等方面进行阐述,为临床医师提供指导和参考。本文对本共识的重要内容进行解读与探讨。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=《糖尿病相关眼病防治多学科中国专家共识》(2021年版)解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=64b7d1c002a56e14, title=《糖尿病相关眼病防治多学科中国专家共识》(2021年版)解读, enTitle=, guiderFrom=临床内科杂志, authorId=0, author=, summary=糖尿病相关眼病严重威胁着糖尿病患者的生存质量,为进一步加深临床医生对其的规范化认识与管理,中华医学会糖尿病学分会糖尿病视网膜病变学组发表了《糖尿病相关眼病防治多学科中国专家共识》,本共识针对糖尿病性视, cover=https://img.medsci.cn/20220531/1653929780694_5579292.png, journalId=0, articlesId=null, associationId=2779, associationName=哈尔滨医科大学附属第一医院内分泌科, associationIntro=哈尔滨医科大学附属第一医院内分泌科, copyright=0, guiderPublishedTime=Sun May 15 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">糖尿病相关眼病严重威胁着糖尿病患者的生存质量,为进一步加深临床医生对其的规范化认识与管理,中华医学会糖尿病学分会糖尿病视网膜病变学组发表了《糖尿病相关眼病防治多学科中国专家共识》,本共识针对糖尿病性视网膜病变及其他眼部并发症患者的筛查、评估与规范化综合管理等方面进行阐述,为临床医师提供指导和参考。本文对本共识的重要内容进行解读与探讨。&nbsp;</span></p>, tagList=[TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=30329, tagName=糖尿病性视网膜病变), TagDto(tagId=438708, tagName=糖尿病性白内障), TagDto(tagId=438709, tagName=糖尿病性角膜病变), TagDto(tagId=438710, tagName=糖尿病性视神经病变)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=38360, appHits=274, showAppHits=0, pcHits=886, showPcHits=38084, likes=1, shares=47, comments=8, approvalStatus=1, publishedTime=Wed Jun 01 15:30:00 CST 2022, publishedTimeString=2022-05-15, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Tue May 31 00:56:41 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Fri Jan 05 14:17:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《糖尿病相关眼病防治多学科中国专家共识》(2021年版)解读.pdf)])
《糖尿病相关眼病防治多学科中国专家共识》(2021年版)解读.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1227300, encodeId=d6db122e30045, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a74680832, createdName=1163771762, createdTime=Sun Jun 19 08:14:43 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225739, encodeId=21eb1225e39ac, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08605478769, createdName=ms2000002069621106, createdTime=Fri Jun 10 23:07:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225575, encodeId=6a7712255e529, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca52621701, createdName=lywyz2, createdTime=Fri Jun 10 07:53:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225084, encodeId=a8a812250849d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Jun 07 22:22:47 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224542, encodeId=269e1224542fd, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cf78170543, createdName=ms5000000043316693, createdTime=Sun Jun 05 13:08:16 CST 2022, time=2022-06-05, status=1, ipAttribution=)]
    2022-06-19 1163771762

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1227300, encodeId=d6db122e30045, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a74680832, createdName=1163771762, createdTime=Sun Jun 19 08:14:43 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225739, encodeId=21eb1225e39ac, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08605478769, createdName=ms2000002069621106, createdTime=Fri Jun 10 23:07:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225575, encodeId=6a7712255e529, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca52621701, createdName=lywyz2, createdTime=Fri Jun 10 07:53:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225084, encodeId=a8a812250849d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Jun 07 22:22:47 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224542, encodeId=269e1224542fd, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cf78170543, createdName=ms5000000043316693, createdTime=Sun Jun 05 13:08:16 CST 2022, time=2022-06-05, status=1, ipAttribution=)]
    2022-06-10 ms2000002069621106

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1227300, encodeId=d6db122e30045, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a74680832, createdName=1163771762, createdTime=Sun Jun 19 08:14:43 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225739, encodeId=21eb1225e39ac, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08605478769, createdName=ms2000002069621106, createdTime=Fri Jun 10 23:07:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225575, encodeId=6a7712255e529, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca52621701, createdName=lywyz2, createdTime=Fri Jun 10 07:53:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225084, encodeId=a8a812250849d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Jun 07 22:22:47 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224542, encodeId=269e1224542fd, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cf78170543, createdName=ms5000000043316693, createdTime=Sun Jun 05 13:08:16 CST 2022, time=2022-06-05, status=1, ipAttribution=)]
    2022-06-10 lywyz2

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1227300, encodeId=d6db122e30045, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a74680832, createdName=1163771762, createdTime=Sun Jun 19 08:14:43 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225739, encodeId=21eb1225e39ac, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08605478769, createdName=ms2000002069621106, createdTime=Fri Jun 10 23:07:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225575, encodeId=6a7712255e529, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca52621701, createdName=lywyz2, createdTime=Fri Jun 10 07:53:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225084, encodeId=a8a812250849d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Jun 07 22:22:47 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224542, encodeId=269e1224542fd, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cf78170543, createdName=ms5000000043316693, createdTime=Sun Jun 05 13:08:16 CST 2022, time=2022-06-05, status=1, ipAttribution=)]
    2022-06-07 眼科芳

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1227300, encodeId=d6db122e30045, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a74680832, createdName=1163771762, createdTime=Sun Jun 19 08:14:43 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225739, encodeId=21eb1225e39ac, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08605478769, createdName=ms2000002069621106, createdTime=Fri Jun 10 23:07:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225575, encodeId=6a7712255e529, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca52621701, createdName=lywyz2, createdTime=Fri Jun 10 07:53:36 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225084, encodeId=a8a812250849d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Jun 07 22:22:47 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224542, encodeId=269e1224542fd, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cf78170543, createdName=ms5000000043316693, createdTime=Sun Jun 05 13:08:16 CST 2022, time=2022-06-05, status=1, ipAttribution=)]
    2022-06-05 ms5000000043316693

    值得学习

    0